Glen W. Barrisford - Concepedia

Author

Glen W. Barrisford

Harvard University

Also Known As

Barrisford, Glen, G BARRISFORD, Glen Barrisford, Glen W Barrisford, Glen W. Barrisford

Publications

918

Citations

H-Index

Concepts

All Affiliations

Harvard University Massachusetts General Hospital Brigham and Women's Hospital Kaiser Permanente Santa Rosa Medical Center

About

Glen W. Barrisford is an author at Harvard University specializing in medicine, urology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	340
2	Obstetrics	2	2	106
3	Public Health	1	1	33
4	Immunology	1	1	52
5	Nephrology	1	1	39

Glen W. Barrisford

Publications

586

Citations

H-Index

Page 1

	Year	Citations
Primary spermatic cord tumors: Disease characteristics, prognostic factors, and treatment outcomes Dayron Rodríguez, Glen W. Barrisford, Alejandro Sánchez, Urologic Oncology Seminars and Original Investigations Prognostic FactorsDisease CharacteristicsUrologySurgical OncologyGynecology	2013	95
Penis Transplantation Curtis L. Cetrulo, Kai Li, Harry M. Salinas, Annals of Surgery	2017	91
Primary genitourinary melanoma: Epidemiology and disease-specific survival in a large population-based cohort Alejandro Sánchez, Dayron Rodríguez, Christopher B. Allard, Urologic Oncology Seminars and Original Investigations Primary Genitourinary MelanomaCancer EpidemiologyDisease-specific SurvivalGenitourinary CancerMedicine	2015	74
Type 2 Diabetes in Relation to the Risk of Renal Cell Carcinoma Among Men and Women in Two Large Prospective Cohort Studies Rebecca E. Graff, Alejandro Sánchez, Deirdre K. Tobias, Diabetes Care	2018	72
Robot-Assisted Laparoscopic Ureteroureterostomy: Description of Technique Carlo C. Passerotti, David A. Diamond, Joseph G. Borer, Journal of Endourology	2008	54
Lexatumumab (TRAIL-receptor 2 mAb) induces expression of DR5 and promotes apoptosis in primary and metastatic renal cell carcinoma in a mouse orthotopic model Liang Zhang, Xiaoping Zhang, Glen W. Barrisford, Cancer Letters Trail-receptor 2ApoptosisImmunologyCell DeathPathology	2006	52
Familial Renal Cancer: Molecular Genetics and Surgical Management Glen W. Barrisford, Eric A. Singer, Inger L. Rosner, International Journal of Surgical Oncology UrologyGenitourinary CancerKidney ResearchMedicineRenal Pathology	2011	39
Clinical features of leiomyosarcoma of the urinary bladder: Analysis of 183 cases Dayron Rodríguez, Mark A. Preston, Glen W. Barrisford, Urologic Oncology Seminars and Original Investigations Urological ResearchUrologyUrologic Cancer EpidemiologyGenitourinary CancerSurgical Pathology	2014	36
Active surveillance for low-risk prostate cancer: Need for intervention and survival at 10 years Mark A. Preston, Adam S. Feldman, John J. Coen, Urologic Oncology Seminars and Original Investigations UrologyCancer EpidemiologyCancer DetectionCancer ScreeningMedicine	2015	33
Active Surveillance of Prostate Cancer is a Viable Option for Men Younger than 60 Years Keyan Salari, David Kuppermann, Mark A. Preston, The Journal of Urology	2019	29

Page 1